https://pubmed.ncbi.nlm.nih.gov/36832258/ Wilson’s disease

Diagnostics (Basel). 2023 Feb 17;13(4):768.
doi: 10.3390/diagnostics13040768.

Prevalence and Significance of Autoantibody Seropositivity in Children with Wilson's Disease

Wojciech Jańczyk 1, Joanna B Bierła 2, Ilona Trojanowska 2, Aldona Wierzbicka-Rucińska 3, Bożena Cukrowska 2, Piotr Socha 1

Abstract

Autoantibodies occur in healthy subjects as well as in children with Wilson's disease (WD), but their prevalence and significance are unknown. Thus, we aimed to assess the prevalence of autoantibodies and autoimmune markers, and their relationship to liver injury in WD children. The study included 74 WD and 75 healthy children as a control group. Patients with WD underwent transient elastography (TE) examinations, as well as determination of liver function tests, copper metabolism markers, and serum immunoglobulins (Ig). In the sera of the WD patients and controls, anti-nuclear (ANA), anti-smooth muscle, anti-mitochondrial, anti-parietal cell, anti-liver/kidney microsomal, anti-neutrophil cytoplasmic autoantibodies, and specific celiac antibodies were determined. Among the autoantibodies, only the prevalence of ANA in children with WD was higher than in the controls. There was no significant relationship between the presence of autoantibodies and liver steatosis or stiffness after TE. However, advanced liver stiffness (E > 8.2 kPa) was related to IgA, IgG, and gamma globulin production. The type of treatment did not influence the prevalence of autoantibodies. Our results suggest that autoimmune disturbances in WD might not be directly related to liver damage as expressed by steatosis and/or liver stiffness after TE.